Not explored in this study, others have reported that peripheral blood sCD163 performance was less than urinary sCD163 for disease activity in LN, but peripheral blood sCD163 can be used to predict non-renal lupus activity in SLE patients including cardiovascular disease, macrophage syndrome, and skin rash among others [[32], [33], [34]]. The gene discussed is CD163; the disease is lobular neoplasia.